Please answer to this discussion post with a minimum of 200 words, cited, APA style. 


The U.S. Preventive Services Task Force is an independent panel of experts in primary care and prevention who Health Screenings are examinations and tests to look for a disease before patients develop any symptoms. It is important because from a medical perspective prevention is better than cure. It is also often easier to treat or indeed cure a condition in its early stages systematically reviews the evidence of effectiveness and develops recommendations for clinical preventive services.  The purpose of screening individuals or populations is to reduce the risk of death or future ill health from a specific condition by offering a test intended to help identify people who could benefit from treatment.  Long and Colorectal cancer screening are tow among others recommendations from US preventing task force.

Lung Cancer (both small cell and non-small cell) is the second most common cancer in both men and women. The American Cancer Society’s estimates for lung cancer in the United States for 2019 are: About 228,150 new cases of lung cancer (116,440 in men and 111,710 in women) About 142,670 deaths from lung cancer (76,650 in men and 66,020 in women). (Society, 2019)

Summary of Recommendation and Evidence for lung Cancer 

Population: Adults Aged 55-80, with a History of Smoking. The USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 55 to 80 years who have a 30 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery. The USPSTF updated its definition of and suggestions for practice for the grades A, B, C, D, and I. Lung Cancer Category B. It means that the screening is high certainty that the net benefit is moderate or there is moderate certainty that the net benefit is moderate to substantial.

On the other hand, Colorectal Cancer is one of the most common cancers diagnosed in the United States. Excluding skin cancers, it is the third most common cancer in both men and women in the U.S.


Adults aged 50 to 75 years. The USPSTF recommends screening for colorectal cancer starting at age 50 years and continuing until age 75 years. The risks and benefits of different screening methods vary. Starting with a simple FBOT or FIT test at the office or sigmoidoscopy every 5 years and colonoscopy every 10 years. The recommendation for this group is category A (The USPSTF recommends the service. There is high certainty that the net benefit is substantial). 

Adults aged 76 to 85 years. The decision to screen for colorectal cancer in adults aged 76 to 85 years should be an individual one, taking into account the patient’s overall health and prior screening history. Adults in this age group who have never been screened for colorectal cancer are more likely to benefit. Screening would be most appropriate among adults who 1) are healthy enough to undergo treatment if colorectal cancer is detected and 2) do not have comorbid conditions that would significantly limit their life expectancy. The recommendation for this group is category C (The USPSTF recommends selectively offering or providing this service to individual patients based on professional judgment and patient preferences. There is at least moderate certainty that the net benefit is small). (Force, 2014)


Force, T. U. (2014, June 12). Recommendations for Primary Care Practice. Retrieved from The U.S. Preventice Services Task Force :

Society, A. C. (2019, May 17). Cancer Facts and Statistics. Retrieved from American Cancer Society: